The year is starting off with a lot of changes and rapid changes in the landscape of several industries, including breakthrough innovations and big transformations. This article delves into several of the most talked-about subjects of 2023, including the most recent advancements in medical cannabis certifications, sustainable hemp business practices, CBD research, and the changing face of CBD activism and advertising on social media.
CBD’s effects on our health
Cannabidiol, often known as CBD, functions by interacting with the endocannabinoid system (ECS) of the body. It is an intricate web of signaling molecules and cell receptors that aids in controlling a variety of physiological functions, such as mood, pain, appetite, and immune system performance. The precise mechanisms remain to be investigated. Nonetheless, studies indicate that analgesic, anxiolytic, and antipsychotic effects are also possible with these therapeutic applications. Let’s see what the most talked-about CBD issues were in 2023.
Liver: a toxicologist’s perspective
Cannabidiol and its effects on the liver have become a central focus for toxicologists. According to expert opinions, CBD can have different impacts on the liver based on dosage, with potential risks associated with high doses, especially when combined with other medications. The call for more comprehensive research, long-term studies, and collaboration between academic institutions, research groups, and industry stakeholders emphasizes the commitment to maximizing CBD’s potential while ensuring consumer health and safety.
CBD for Leigh Syndrome
As we recently wrote, EMA made a remarkable decision. It designated cannabidiol (CBD) as an orphan drug for the treatment of Leigh syndrome, a rare mitochondrial disorder. Researchers from the Mitochondrial Neuropathology Research Group at the UAB Institut de Neurociències (INc-UAB), including Drs. Emma Puighermanal, Albert Quintana, and Elisenda Sanz, petitioned for this judgement. Each identification of an orphan drug is a key step in developing new therapies for rare diseases with few available therapeutic choices.
Updates on leading European corporations
In 2023, the cannabis sector is expected to witness significant breakthroughs and strategic advancements as it continues its dynamic expansion. We reviewed the most recent information from well-known cannabis businesses. From noteworthy advancements in the certification of medical cannabis to creative partnerships and environmental projects. These updates highlight the cannabis industry’s tenacity and expansion in negotiating the intricate web of laws, shifting consumer demands, and competitive market conditions.
Certification for GMP and Swisscann
With its Good Manufacturing Practice (GMP) certification, Swisscann Tec AG has accomplished a noteworthy milestone in the constantly changing medicinal cannabis market. With this certification, the business establishes itself as a pioneer in the field and sets the standard for excellence and creativity. The dedication of Swisscann Tec AG to quality is apparent, and this represents a significant advancement in the use of medical cannabis for therapeutic purposes.
Growth of SOMAÍ Pharmaceuticals
The collaboration between Canna Forest and SOMAÍ Pharmaceuticals represents a big step forward in the development of cannabis-based medications. This partnership, which gives patients access to a variety of medications with different extract APIs, demonstrates the commitment of both businesses to delivering top-notch medical treatments globally. The collaboration prioritizes creativity and the search for the ideal combination of medicinal extracts to meet the demands of specific patients.
Ukrainian Hemp®: a sustainable future
A company established with the goal of supplying industrial hemp raw materials to various sectors. Ukrainian Hemp® is committed to reducing the environmental impact of businesses, particularly in the sustainable packaging industry. By harnessing the natural qualities of industrial hemp, the company aims to surpass traditional sources like wood cellulose in terms of sustainability and usefulness, contributing to a more environmentally friendly supply chain.
Ananda Developments in 2023
Ananda Developments PLC has positioned itself as a frontrunner in the realm of cannabinoid-based medicines. It marked a series of recent achievements that underscore its commitment to innovation and research. The introduction of MRX1 and MRX2, coupled with ongoing clinical trials and patent pursuits, reflects the company’s dedication to advancing medical solutions. Ananda aspires to make a substantial impact on the medical sector. Particularly with the potential support of the NHS on the horizon. The company’s emphasis on providing medications to those in need, especially for non-pharmaceutical pain management options, presents a promising future for patients seeking alternatives.
Ananda Developments has a global leadership position in innovation and research. Its pioneering mission aims to redefine cannabinoid-based medications. All by its ambitious endometriosis randomized controlled trial utilizing the innovative MRX1 cannabidiol oil. Supported by the Chief Scientist Office, this venture receives substantial non-dilutive funding, amounting to £300,000, showcasing Ananda’s commitment to advancing medical research and solutions.
CBD market changes
A comprehensive report on the European CBD market highlights Germany’s continued dominance, accounting for over 30% of the market share. The report identifies Austria, Switzerland, and the United Kingdom as crucial markets with potential for growth. The European CBD market is characterized by fragmentation, with numerous small and medium-sized businesses competing. However, the analysis predicts future consolidation. It is because larger businesses seek to enhance market share. Additionally, smaller ones navigate heightened competition and regulatory pressures.
Meta’s approach to CBD advertising
Another top topic for cannabis industry was the new approach for CBD advertising managed by Meta. This parent company of social media giants Facebook, Instagram, and Thread, has adopted a groundbreaking approach to CBD advertising. By changing its advertising policy from “Hemp and related products” to “CBD and related products,” Meta signals a readiness to embrace the expanding CBD market. This move takes into account the changing attitudes toward cannabis-derived goods and encourages ethical marketing practices.
Germany: cannabis legalisation
And, finally, all the turbulences within cannabis Germany in the year 2023. This country finds itself at the forefront of a transformative journey in the realm of cannabis legalisation. It is navigating a path that balances the potential benefits with the legal intricacies involved. The cannabis industry, buoyed by anticipation, looks to Germany as a potential powerhouse with the prospect of legalisation on the horizon.
Yet, the journey is riddled with legal complexities, as fears persist that international and EU laws might impede or slow down the ambitious project. Government ministers justify their measures by emphasising the overarching goal of combating the illegal cannabis market and related criminal activities. A notable initiative its the establishment of Cannabis Social Clubs in Germany. It signifies a progressive step towards providing a legal and credible source of cannabis, while also addressing concerns about the black market’s ties to organised crime. The German government meticulously evaluates diverse approaches to legalisation. Thus, considerations extend to repurposing also old sheds into these social clubs, showcasing an innovative and adaptable approach.
Simultaneously, Germany grapples with the intricacies of cannabis and youth protection, as proposed legislation takes centre stage. This legislative advancement represents a substantial step forward. But it also sparks debates about adolescent protection and drug policies. It draws input from various sectors such as health professionals, educators, law enforcement, and advocacy groups. The German Bundestag’s prolonged efforts toward cannabis legalisation. It included scientific services cooperation, what underscored the commitment to a comprehensive and well-informed decision-making process, even as scepticism about compliance with European law is expressed by the scientific service. Germany’s initiatives navigate a cautious path. However they may serve as a model for countries grappling with similar issues. Germany shows the importance of evidence-based policies and comprehensive youth protection measures for a healthier and safer future generation.
The power of Twitter in Germany: #Weedmob
Social media’s influence is evident in Germany, where the #Weedmob trend on Twitter was gaining momentum. This social media activism aimed to raise awareness and mobilize the Federal Constitutional Court to address pending judgments related to cannabis. The power of Twitter is harnessed to unite activists, transcend boundaries, and bring attention to issues that demand justice.
Let’s summarise 2023
The top topics of 2023 reflect the dynamic nature of industries related to CBD, medical cannabis and hemp. As these trends unfold, they signify a collective commitment to innovation, sustainability, and responsible practices, paving the way for a future that maximizes the potential of these industries while prioritizing the well-being of consumers and the planet.